Home › Focal Segmental Glomerulosclerosis › Texas
Pag-aaral pangklinika para sa Focal Segmental Glomerulosclerosis sa Texas
5 pag-aaral para sa Focal Segmental Glomerulosclerosis ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
Opisyal na teksto ng pag-aaral (English)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #5, Arlington
- Investigator Site #21, Dallas
- Investigator Site #9, Dallas
- at 1 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Texas Tech University Health Sciences Center-Amarillo-63885, Amarillo
- The Healing Kidneys Institute, Conroe
- Advanced Dallas Hospital and Clinics, Dallas
- at 4 pa
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Nagre-recruitPhase 2
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 80 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
Nagre-recruitPhase 2
Edad 1 hanggang 17 · Lahat ng kasarian · Na-update May 12, 2026 · NCT05003986Mula sa ClinicalTrials.gov, na-kuha noong Okt 2, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.